Bluesky Facebook Reddit Email

Potential biomarker for chronic fatigue syndrome

04.29.19 | Proceedings of the National Academy of Sciences

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.


A study suggests a potential diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). More than 2 million Americans are afflicted by ME/CFS, a debilitating condition of uncertain etiology thought to be triggered by infectious agents, among other putative factors. However, a diagnostic biomarker continues to elude researchers. Based on the hypothesis that exposing blood cells to salt-induced osmotic stress forces the cells to devour ATP, a cellular energy metabolite thought to be deficient in ME/CFS patients, Rahim Esfandyarpour, Ronald Davis, and colleagues developed a blood-based assay for CFS. The assay, performed using a high-throughput nanoelectronic needle array, measures changes in electrical impedance in blood cells exposed to plasma salt concentrations of 200 mmol/L—a hyperosmotic stress that mimics the exertion-induced malaise experienced by ME/CFS patients. Comparison of the electrical response of hyperosmotically stressed blood cells from a bedridden ME/CFS patient and healthy control revealed marked differences in impedance changes, providing the basis of a potential diagnostic signature for ME/CFS. The authors validated the signature in a separate cohort of 20 healthy controls and 20 ME/CFS patients of varying disease severity who had been diagnosed by a physician using the established Canadian Consensus Criteria (CCC). Plasma samples used within 5 hours of preparation at 200 cells/µL yielded the most reproducible results. Additionally, the authors paired the assay with a machine-learning algorithm to develop a diagnostic classifier for new ME/CFS patients. According to the authors, though the assay’s mechanistic underpinnings remain unexplored, the findings present a potential blood-based diagnostic biomarker that can complement CCC and aid ME/CFS drug screening efforts.

MEDIA CONTACT: Rahim Esfandyarpour, University of California, Irvine, CA; tel: 650-387-5976; e-mail: rahimes@uci.edu ; Ronald Davis, Stanford University, Palo Alto, CA; tel: 650-721-5614; e-mail: krhong@stanford.edu

###

Proceedings of the National Academy of Sciences

Keywords

Article Information

Contact Information

Rahim Esfandyarpour
rahimes@uci.edu

How to Cite This Article

APA:
Proceedings of the National Academy of Sciences. (2019, April 29). Potential biomarker for chronic fatigue syndrome. Brightsurf News. https://www.brightsurf.com/news/LR57R5R8/potential-biomarker-for-chronic-fatigue-syndrome.html
MLA:
"Potential biomarker for chronic fatigue syndrome." Brightsurf News, Apr. 29 2019, https://www.brightsurf.com/news/LR57R5R8/potential-biomarker-for-chronic-fatigue-syndrome.html.